Trials / Unknown
UnknownNCT04088279
Novel Quantitative Magnetic Resonance Imaging (MRI) Measures in the Assessment and Follow-up of Patients With Pulmonary Hypertension (PH)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Royal Brompton & Harefield NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective study of the use of two novel MRI techniques (oxygen-enhanced and fourier decomposition MRI) in the initial diagnosis and follow-up of patients with Pulmonary Hypertension. The investigators believe these techniques may present a novel set of imaging biomarkers that may be used for risk stratification, prediction of treatment response and longitudinal disease monitoring. The reserach MRI is in addition to standard of care and will not affect treatment decisions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | MRI | Oxygen enhanced and fourier decomposition MRI |
Timeline
- Start date
- 2018-11-19
- Primary completion
- 2020-12-01
- Completion
- 2021-06-01
- First posted
- 2019-09-12
- Last updated
- 2019-09-12
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04088279. Inclusion in this directory is not an endorsement.